Medicaid Managed Care - U.S. Senate Special Committee on Aging

130
to use, and they will be collected at the end of the presentations
when we have our discussion.
Our final forum will be next week. At that time, our panelists
will discuss problems faced by States that want to contract to purchase
managed care plans for their <strong>Medicaid</strong> beneficiaries with special
needs. That forum will be next Tuesday in this room at 9:30
in the morning.
Ultimately, the <strong>Committee</strong> plans to publish the information generated
by these forums and make it available to Congress and the
public.
Once again, I need to thank LaVita Westbrook who is the organizer
of alI the details of these forums; without her, they would not
happen.
Today our panelists are Bill Scanlon, who is Director of the
Health Financing and Systems Issue Area at the U.S. General Accounting
Office, GAO. He has been engaged in health services research
since 1975. Before joining GAO in 1993, Dr. Scanlon was co-
Director of the Center for Health Policy Studies and an associate
professor in the Department of Family Medicine at Georgetown
University. His research has focused in particular on the Medicare
and <strong>Medicaid</strong> programs, especially provider payment policies, and
the provision and financing of long-term care services.
We also have today Dr. Michael Collins, who is Deputy Executive
Director at the Center for Health Program Development and Management
at the University of Maryland Baltimore County. The
Center is a health policy and information consulting firm within
the State government. Dr. Collins's professional concentrations are
in health care information and decision support systems, quality
measurement, and program development and evaluation. He has
worked with a wide variety of for-profit and nonprofit, private and
public, U.S. and international organizations.
We also welcome John Ware. Dr. Ware is a Senior Scientist in
The Health Institute at New England Medical Center and on the
faculty at Tufts University School of Medicine and the Harvard
School of Public Health. He is a member of the Institute of Medicine
and serves on the board of directors of the Medical Outcomes
Trust. Since 1984, Dr. Ware has served as principal investigator for
the Medical Outcomes Study, which developed the SF-36 Health
Survey and other tools widely used in monitoring outcomes for patients.
Prior to joining The Health Institute in 1988, Dr. Ware was
a senior research psychologist for 14 years at the RAND Corporation.
Finally, we welcome Trish MacTaggart. Ms. MacTaggart is the
Director, Quality and Performance Management, Center for <strong>Medicaid</strong>
and State Operations, in the newly reorganized Health <strong>Care</strong> Financing
Administration, HCFA. She previously provided leadership
in the development of Section 1115 waivers in the Office of State
Health Reform Demonstrations at HCFA. Prior to coming to HCFA
in March, Ms. MacTaggart was Director of the <strong>Medicaid</strong> program
for Minnesota.
I am going to turn it over to Dr. Scanlon, and I believe the panel
has decided amongst themselves what order they wish to go in, so
I'll just let them take off. Each panelist will speak for about 5 or
10 minutes, and then well have questions.